CVAC
CurevacยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CVAC Profile
Curevac N.V.
A biopharmaceutical company that develops mRNA-based vaccines and therapies for infectious diseases and cancer treatments
Friedrich-Miescher-Strasse 15, 72076, Tubingen, Germany
--
Curevac N.V. was incorporated under the laws of the Netherlands on April 7, 2020. The company is a global clinical-stage biopharmaceutical company developing novel translational drugs based on messenger ribonucleic acid that have the potential to improve people's lives.
